Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban
- 1 December 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (12) , 1421-1423
- https://doi.org/10.1016/s0002-9149(02)02892-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Platelet inhibition with tirofiban early during percutaneous coronary intervention: Dosing revisitedCatheterization and Cardiovascular Interventions, 2002
- Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary interventionThe American Journal of Cardiology, 2002
- Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventionsThe American Journal of Cardiology, 2002
- American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of CardiologyJournal of the American College of Cardiology, 2001
- Platelet Reactivity Characterized ProspectivelyCirculation, 2001
- Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2001
- Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximabCoronary Artery Disease, 2001
- Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stentingJournal of the American College of Cardiology, 2001
- Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor AntagonistsJournal of Thrombosis and Thrombolysis, 2000
- Differential Effects of Anticoagulants on the Activation of Platelets Ex VivoCirculation, 1997